Several other analysts have also weighed in on the stock. Commerzbank set a €53.00 ($61.63) price objective on shares of Compugroup Medical and gave the stock a buy rating in a report on Tuesday, September 11th. Berenberg Bank set a €49.00 ($56.98) price objective on shares of Compugroup Medical and gave the stock a neutral rating in a report on Monday, August 13th. Warburg Research set a €53.50 ($62.21) price objective on shares of Compugroup Medical and gave the stock a buy rating in a report on Friday, August 10th. Deutsche Bank set a €62.00 ($72.09) price objective on shares of Compugroup Medical and gave the stock a buy rating in a report on Tuesday, August 14th. Finally, HSBC set a €57.00 ($66.28) price target on shares of Compugroup Medical and gave the company a buy rating in a report on Wednesday, July 4th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the company. The company presently has an average rating of Buy and a consensus price target of €52.19 ($60.68).
ETR COP opened at €46.52 ($54.09) on Wednesday. Compugroup Medical has a 1-year low of €40.10 ($46.63) and a 1-year high of €60.30 ($70.12).
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.
Featured Story: How to Profit and Limit Losses With Stop Orders
Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.